Literature DB >> 33039560

Palmitic acid negatively regulates tumor suppressor PTEN through T366 phosphorylation and protein degradation.

Dongmei Bai1, Yong Wu1, Poonamjot Deol2, Yumiko Nobumori1, Qi Zhou1, Frances M Sladek2, Xuan Liu3.   

Abstract

Chronic elevated free fatty (FFA) levels are linked to metabolic disorders and tumorigenesis. However, the molecular mechanism by which FFAs induce cancer remains poorly understood. Here, we show that the tumor suppressor PTEN protein levels were decreased in high fat diet (HFD) fed mice. As palmitic acid (PA, C16:0) showed a significant increase in the HFD fed mice, we further investigated its role in PTEN down regulation. Our studies revealed that exposure of cells to high doses of PA induced mTOR/S6K-mediated phosphorylation of PTEN at T366. The phosphorylation subsequently enhanced the interaction of PTEN with the E3 ubiquitin ligase WW domain-containing protein 2 (WWP2), which promoted polyubiquitination of PTEN and protein degradation. Consistent with PTEN degradation, exposure of cells to increased concentrations of PA also promoted PTEN-mediated AKT activation and cell proliferation. Significantly, a higher level of S6K activation, PTEN T366 phosphorylation, and AKT activation were also observed in the livers of the HFD fed mice. These results provide a molecular mechanism by which a HFD and elevated PA regulate cell proliferation through inactivation of tumor suppressor PTEN. Published by Elsevier B.V.

Entities:  

Keywords:  PTEN; Palmitic acid; S6K; T366 phosphorylation; mTOR

Year:  2020        PMID: 33039560     DOI: 10.1016/j.canlet.2020.10.007

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Metabolic network-based identification of plasma markers for non-small cell lung cancer.

Authors:  Linling Guo; Linrui Li; Zhiyun Xu; Fanchen Meng; Huimin Guo; Peijia Liu; Peifang Liu; Yuan Tian; Fengguo Xu; Zunjian Zhang; Shuai Zhang; Yin Huang
Journal:  Anal Bioanal Chem       Date:  2021-10-07       Impact factor: 4.142

2.  UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer.

Authors:  Gang Xiang; Shuxuan Wang; Ling Chen; Mei Song; Xiaoxu Song; Huan Wang; Pengbo Zhou; Xiaojing Ma; Jing Yu
Journal:  Cell Death Dis       Date:  2022-05-12       Impact factor: 9.685

Review 3.  Quantitative proteomics characterization of cancer biomarkers and treatment.

Authors:  Xiao-Li Yang; Yi Shi; Dan-Dan Zhang; Rui Xin; Jing Deng; Ting-Miao Wu; Hui-Min Wang; Pei-Yao Wang; Ji-Bin Liu; Wen Li; Yu-Shui Ma; Da Fu
Journal:  Mol Ther Oncolytics       Date:  2021-04-20       Impact factor: 7.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.